Novaquest Capital Management, L.L.C 13F annual report

Novaquest Capital Management, L.L.C is an investment fund managing more than $54.3 million ran by John Jr.. There are currently 2 companies in Mr. Jr.’s portfolio. The largest investments include Myovant Sciences and Revance Therapeutics, together worth $54.3 million.

$54.3 million Assets Under Management (AUM)

As of 6th November 2020, Novaquest Capital Management, L.L.C’s top holding is 3,474,645 shares of Myovant Sciences currently worth over $48.8 million and making up 90.0% of the portfolio value. Relative to the number of outstanding shares of Myovant Sciences, Novaquest Capital Management, L.L.C owns more than approximately 0.1% of the company. In addition, the fund holds 216,038 shares of Revance Therapeutics worth $5.43 million, whose value grew 37.6% in the past six months.

Currently, Novaquest Capital Management, L.L.C's portfolio is worth at least $54.3 million. The total portfolio value may be much higher due to cash assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.

Careers at Novaquest Capital Management, L.L.C

The Novaquest Capital Management, L.L.C office and employees reside in Raleigh, North Carolina. According to the last 13-F report filed with the SEC, John Jr. serves as the Manager at Novaquest Capital Management, L.L.C.

Recent trades

John Jr. disclosed a decreased stake in Revance Therapeutics by 0.6%. This leaves the value of the investment at $5.43 million and 216,038 shares.

One of the smallest hedge funds

The two most similar investment funds to Novaquest Capital Management, L.L.C are Youngs Advisory Group, Inc and Davis Capital Management. They manage $54.1 million and $54.1 million respectively.

John Jr. investment strategy

Novaquest Capital Management, L.L.C’s portfolio is diversified across 1 sector. Currently, their heaviest sector is Health Care — making up 100.0% of the total portfolio value. The fund focuses on investments in the United Kingdom as 50.0% of the portfolio companies are based in the United Kingdom.

The majority of the companies in the fund’s portfolio are large-cap stocks. Stocks with a size of more than $10 billion in market cap make up approximately 0.1% of the total holdings value. On the other hand, small-cap stocks make up only approximately 0.1% of the portfolio. The average market cap of the portfolio companies is close to $1.47 billion.

The complete list of Novaquest Capital Management, L.L.C trades based on 13F SEC filings

These positions were updated on November 13th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.

Security	Shares Owned	Value	Allocation
Myovant Sciences Ltd.	No change 3,474,645	$48,819,000	89.99%
Revance Therapeutics, Inc.	63.93% 216,038	$5,431,000	10.01%
No transactions found
Showing first 500 out of 2 holdings